Impact Biomedical (IBO) Non Operating Interest Expenses (2022 - 2025)
Impact Biomedical (IBO) recorded Non Operating Interest Expenses of $262,000 in Q3 2025, down 14.1% from $305,000 a year earlier but up 0.8% from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Non Operating Interest Expenses (2022 - 2025) Analysis & Trends
On a TTM basis, Impact Biomedical's Non Operating Interest Expenses came in at $1.06 million as of Sep 30, 2025, up 15.4% year-over-year; for FY2024, it was $1.07 million, up 139.9% from FY2023.
- Across earlier years, Non Operating Interest Expenses came in at $444,000 in FY2023 (-3.9%) and $462,000 in FY2022.
- Quarterly Non Operating Interest Expenses has ranged from $92,000 in Q3 2022 to $305,000 in Q3 2024 over the past five years.
- On a year-over-year basis, Non Operating Interest Expenses rose in six of the last eight quarters, with growth averaging 74.7%.
- Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 199.0% in Q3 2024, against a decline of 16.5% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $260,000 (Q2 2025), $271,000 (Q1 2025) and $270,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Impact Biomedical | 598.41 Mn | 601.61 Mn | 2,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 262,000.00 |
| Jun 30, 2025 | 260,000.00 |
| Mar 31, 2025 | 271,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Sep 30, 2024 | 305,000.00 |
| Jun 30, 2024 | 261,000.00 |
| Mar 31, 2024 | 230,000.00 |
| Dec 31, 2023 | 125,000.00 |
| Sep 30, 2023 | 102,000.00 |
| Jun 30, 2023 | 116,000.00 |
| Mar 31, 2023 | 101,000.00 |
| Dec 31, 2022 | 99,000.00 |
| Sep 30, 2022 | 92,000.00 |
| Jun 30, 2022 | 139,000.00 |
API Access
Impact Biomedical Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();